Read more

November 01, 2022
1 min read
Save

Fox Chase Cancer Center names president, CEO

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Robert Uzzo, MD, MBA, FACS, has been named president and CEO of Fox Chase Cancer Center.

Robert Uzzo
Robert Uzzo

Uzzo, who had served as interim CEO for nearly a year, also will serve as executive vice president of cancer services for Temple University Health System and senior associate dean of clinical cancer research at Lewis Katz School of Medicine at Temple University. He will also retain the role of G. Willing “Wing” Pepper chair in cancer research.

Michael A Young

“Dr. Uzzo is an internationally recognized urologic cancer surgeon and researcher with a proven track record of leadership success in the complex academic medical center setting, building innovative academic and research programs and strengthening clinical care,” Michael A. Young, MHA, FACHE, president and CEO of Temple University Health System, said in a press release. “Respected by patients and colleagues alike, he is a compassionate leader who is uniquely qualified to guide Fox Chase’s success well into the future.”

Uzzo joined Fox Chase in 2000 after completing fellowship training at Cleveland Clinic.

Uzzo — recognized for his expertise in open, laparoscopic and robotic urologic surgery — is trained in organ-sparing and reconstructive surgical techniques. He previously served as chair of Fox Chase’s department of surgery.

“Dr. Uzzo is passionate about the mission of Fox Chase Cancer Center and approaches his leadership roles with a sense of conviction, collaboration and inclusion. This work extends throughout our Temple Health community as we partner together to deliver excellent cancer care to even more patients,” Young said in the release.